Epix Pharmaceuticals Inc (formerly Predix Pharmaceuticals Inc) was a pharmaceutical company based in Lexington, Massachusetts. Its products included the following agents: * PRX-00023—5-HT1A receptor full agonist (later discovered to be an antagonist): for major depression and generalized anxiety disorder * PRX-03140—5-HT4 receptor partial agonist: for Alzheimer's disease * PRX-07034—5-HT6 receptor antagonist: for obesity and cognitive impairment associated with Alzheimer's disease and schizophrenia * PRX-08066—5-HT2B receptor antagonist: for pulmonary hypertension associated with chronic obstructive pulmonary disease

Property Value
dbo:abstract
  • Epix Pharmaceuticals Inc (formerly Predix Pharmaceuticals Inc) was a pharmaceutical company based in Lexington, Massachusetts. Its products included the following agents: * PRX-00023—5-HT1A receptor full agonist (later discovered to be an antagonist): for major depression and generalized anxiety disorder * PRX-03140—5-HT4 receptor partial agonist: for Alzheimer's disease * PRX-07034—5-HT6 receptor antagonist: for obesity and cognitive impairment associated with Alzheimer's disease and schizophrenia * PRX-08066—5-HT2B receptor antagonist: for pulmonary hypertension associated with chronic obstructive pulmonary disease As of July 2009, the company was in the process of asset liquidation due to insufficient funds to stay afloat. (en)
dbo:wikiPageEditLink
dbo:wikiPageExternalLink
dbo:wikiPageExtracted
  • 2019-06-10 06:46:18Z (xsd:date)
dbo:wikiPageHistoryLink
dbo:wikiPageID
  • 26102017 (xsd:integer)
dbo:wikiPageLength
  • 1943 (xsd:integer)
dbo:wikiPageModified
  • 2019-05-07 02:11:07Z (xsd:date)
dbo:wikiPageOutDegree
  • 31 (xsd:integer)
dbo:wikiPageRevisionID
  • 895880114 (xsd:integer)
dbo:wikiPageRevisionLink
dbp:wikiPageUsesTemplate
dct:subject
rdfs:comment
  • Epix Pharmaceuticals Inc (formerly Predix Pharmaceuticals Inc) was a pharmaceutical company based in Lexington, Massachusetts. Its products included the following agents: * PRX-00023—5-HT1A receptor full agonist (later discovered to be an antagonist): for major depression and generalized anxiety disorder * PRX-03140—5-HT4 receptor partial agonist: for Alzheimer's disease * PRX-07034—5-HT6 receptor antagonist: for obesity and cognitive impairment associated with Alzheimer's disease and schizophrenia * PRX-08066—5-HT2B receptor antagonist: for pulmonary hypertension associated with chronic obstructive pulmonary disease (en)
rdfs:label
  • Epix Pharmaceuticals (en)
owl:sameAs
foaf:isPrimaryTopicOf
is dbo:wikiPageRedirects of
is foaf:primaryTopic of